These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8817341)

  • 1. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene.
    Lüdecke B; Knappskog PM; Clayton PT; Surtees RA; Clelland JD; Heales SJ; Brand MP; Bartholomé K; Flatmark T
    Hum Mol Genet; 1996 Jul; 5(7):1023-8. PubMed ID: 8817341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene.
    Knappskog PM; Flatmark T; Mallet J; Lüdecke B; Bartholomé K
    Hum Mol Genet; 1995 Jul; 4(7):1209-12. PubMed ID: 8528210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency.
    Bräutigam C; Steenbergen-Spanjers GC; Hoffmann GF; Dionisi-Vici C; van den Heuvel LP; Smeitink JA; Wevers RA
    Clin Chem; 1999 Dec; 45(12):2073-8. PubMed ID: 10585338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.
    Clot F; Grabli D; Cazeneuve C; Roze E; Castelnau P; Chabrol B; Landrieu P; Nguyen K; Ponsot G; Abada M; Doummar D; Damier P; Gil R; Thobois S; Ward AJ; Hutchinson M; Toutain A; Picard F; Camuzat A; Fedirko E; Sân C; Bouteiller D; LeGuern E; Durr A; Vidailhet M; Brice A;
    Brain; 2009 Jul; 132(Pt 7):1753-63. PubMed ID: 19491146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype.
    Haugarvoll K; Bindoff LA
    J Parkinsons Dis; 2011; 1(1):119-22. PubMed ID: 23939262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population.
    van den Heuvel LP; Luiten B; Smeitink JA; de Rijk-van Andel JF; Hyland K; Steenbergen-Spanjers GC; Janssen RJ; Wevers RA
    Hum Genet; 1998 Jun; 102(6):644-6. PubMed ID: 9703425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.
    Schiller A; Wevers RA; Steenbergen GC; Blau N; Jung HH
    Neurology; 2004 Oct; 63(8):1524-6. PubMed ID: 15505183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
    Tan D; Zhang Y; Ye J; Han L; Qiu W; Gu X; Zhang H
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):616-9. PubMed ID: 25224241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of tyrosine 3-monooxygenase and inherited diseases.
    Kobayashi K; Nagatsu T
    Biochem Biophys Res Commun; 2005 Dec; 338(1):267-70. PubMed ID: 16105653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.
    Diepold K; Schütz B; Rostasy K; Wilken B; Hougaard P; Güttler F; Romstad A; Birk Møller L
    Mov Disord; 2005 Jun; 20(6):764-7. PubMed ID: 15747353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four novel mutations in the tyrosine hydroxylase gene in patients with infantile parkinsonism.
    Swaans RJ; Rondot P; Renier WO; Van Den Heuvel LP; Steenbergen-Spanjers GC; Wevers RA
    Ann Hum Genet; 2000 Jan; 64(Pt 1):25-31. PubMed ID: 11246459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational study of human tyrosine hydroxylase mutants to uphold [4-(Propan-2-yl) Phenyl]Carbamic acid as a potential inhibitor.
    Nawaz MS; Parveen Z; Wang L; Rashid S; Fatmi MQ; Kamal MA
    CNS Neurol Disord Drug Targets; 2014; 13(7):1169-74. PubMed ID: 25230230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.
    Ortez C; Duarte ST; Ormazábal A; Serrano M; Pérez A; Pons R; Pineda M; Yapici Z; Fernández-Álvarez E; Domingo-Jiménez R; De Castro P; Artuch R; García-Cazorla A
    Mol Genet Metab; 2015 Jan; 114(1):34-40. PubMed ID: 25468651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A homozygous tyrosine hydroxylase gene promoter mutation in a patient with dopa-responsive encephalopathy: clinical, biochemical and genetic analysis.
    Ribasés M; Serrano M; Fernández-Alvarez E; Pahisa S; Ormazabal A; García-Cazorla A; Pérez-Dueñas B; Campistol J; Artuch R; Cormand B
    Mol Genet Metab; 2007 Nov; 92(3):274-7. PubMed ID: 17698383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new knock-in mouse model of l-DOPA-responsive dystonia.
    Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ
    Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.